The Europe Pen Needles Market is projected to grow from USD 0.72 billion in 2026 to USD 1.10 billion by 2031, registering a CAGR of 8.9% during the forecast period. Market expansion is primarily driven by increasing diabetes prevalence, growing adoption of GLP-1 therapies, supportive reimbursement frameworks, and the rising shift toward home-based care.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159977651
Market Growth Overview
Across Europe, governments and healthcare systems are strengthening initiatives to improve access to essential diabetes management tools, including insulin pens and pen needles. Reimbursement and partial coverage policies in several countries are reducing financial barriers and encouraging better treatment adherence.
National awareness campaigns focused on proper insulin administration and regular glucose monitoring are further improving patient compliance and reducing long-term complications. These coordinated efforts are significantly increasing the utilization of pen needles across the region and elevating the overall standard of diabetes care.
Standard Pen Needles Dominated the Market in 2025
By type, the standard pen needles segment accounted for the largest share of the Europe pen needles market in 2025.
Government reimbursement programs and educational initiatives have supported widespread adoption of standard pen needles, particularly in insulin-dependent diabetes management. These devices remain widely preferred due to affordability, familiarity among patients and clinicians, and compatibility with multiple insulin delivery systems.
Strong institutional backing and improved accessibility continue to reinforce the segment’s leading position.
Online Purchase Segment to Register Highest CAGR
The online purchase segment is expected to grow at the highest CAGR during the forecast period.
Rising e-commerce penetration in healthcare, increased patient preference for convenience, and improved access for individuals in remote or mobility-restricted settings are driving online sales growth. Digital pharmacy platforms offer: Competitive pricing, Subscription-based refill models, Discreet home delivery, and Broader product selection
Expanding pharmacy e-commerce networks and supportive regulatory frameworks across Europe are accelerating this shift toward digital procurement channels.
France Expected to Lead Regional Growth
France is projected to register the highest growth rate during the forecast period.
Growth in France is supported by:
1. A strong national diabetes management program
2. Increased reimbursement coverage for insulin delivery devices
3. Rising adoption of injectable insulin and GLP-1 therapies
4. Expanding e-pharmacy infrastructure
5. Greater acceptance of online medical purchases
Additionally, the government’s emphasis on safety in clinical and home-care settings is encouraging the adoption of safety pen needles. Combined with robust patient education initiatives and improved healthcare access, France presents a highly favorable growth environment within the European market.
Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=159977651
Competitive Landscape
Leading companies in the Europe pen needles market are focusing on product innovation, geographic expansion, partnerships, and acquisitions to strengthen their market presence.
Prominent players include: Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), B. Braun SE (Germany), Owen Mumford (UK), Terumo Corporation (Japan), NIPRO Corporation (Japan), Allison Medical, Inc. (US), AdvaCare Pharma (US), Berpu Medical Technology Co., Ltd. (China), GlucoRx Limited (UK), HTL-STREFA (Poland), UltiMed, Inc. (US), Hindustan Syringes and Medical Devices (India), Artsana Group (Italy), VOGT Medical Vertrieb GmbH (Germany), Van Heek Medical (Netherlands), Simple Diagnostics (US), IYON Medical (Turkey), Links Medical Products, Inc. (US), and MHC Medical Products, LLC (US).
Strategic Outlook
With rising diabetes prevalence, expanding GLP-1 therapy adoption, and increasing demand for home-based self-administration, the Europe pen needles market is positioned for steady long-term growth.
Reimbursement support, digital pharmacy expansion, patient education programs, and innovation in safety-enhanced devices will remain central to competitive differentiation. Markets that successfully integrate reimbursement access, e-commerce infrastructure, and patient-centric device design are likely to capture the greatest share of growth through 2031.
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/europe-pen-needles-market-159977651.html